Literature DB >> 3978315

Pharmacological characterization of the slow component of deactivation of guinea-pig isolated ileum to the spasmogenic action of C5adesArg.

B Damerau, J Roesler, W Vogt.   

Abstract

The slow component of deactivation of guinea-pig isolated ileum to C5adesArg was studied to analyse the mechanism of loss and subsequent recovery of sensitivity. Neither cycloheximide (10(-3) M) nor colchicine (5 X 10(-5) M), vinblastine, lumicolchicine, or cytochalasin B (each 2 X 10(-5) M) affected significantly the spasmogenic effect of C5adesArg or the course of deactivation produced by repeated applications; chloroquine (2 X 10(-4) M) inhibited the spasmogenic effect unspecifically without interfering with deactivation. Recovery from slow deactivation was totally blocked by chloroquine and considerably diminished by colchicine and vinblastine, but was not affected by the other agents. It is proposed that recovery involves lysosomal processing of C5a receptors (occupied by the peptide) but does not require biosynthesis of new receptors.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3978315      PMCID: PMC1987203     

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  22 in total

1.  An analysis of the inhibitory effects and of possible prostaglandins antagonism of chloroquine in the guinea-pig isolated ileum.

Authors:  J Famaey; J Fontaine; J Reuse
Journal:  J Pharm Pharmacol       Date:  1977-12       Impact factor: 3.765

2.  Fluorescence probe measurement of the intralysosomal pH in living cells and the perturbation of pH by various agents.

Authors:  S Ohkuma; B Poole
Journal:  Proc Natl Acad Sci U S A       Date:  1978-07       Impact factor: 11.205

3.  Effects of some antimalarials and related substances on intralysosomal proteolysis.

Authors:  J L Mego; C H Chung
Journal:  Biochem Pharmacol       Date:  1979       Impact factor: 5.858

Review 4.  Commentary. Lysosomotropic agents.

Authors:  C de Duve; T de Barsy; B Poole; A Trouet; P Tulkens; F Van Hoof
Journal:  Biochem Pharmacol       Date:  1974-09-15       Impact factor: 5.858

Review 5.  Lysosomal functions in cellular activation: propagation of the actions of hormones and other effectors.

Authors:  C M Szego; R J Pietras
Journal:  Int Rev Cytol       Date:  1984

6.  Complement-mediated release of histamine from human basophils. III. Possible regulatory role of microtubules and microfilaments.

Authors:  J A Grant; E Dupree; D O Thueson
Journal:  J Allergy Clin Immunol       Date:  1977-11       Impact factor: 10.793

7.  Cytochalasins block actin filament elongation by binding to high affinity sites associated with F-actin.

Authors:  M D Flanagan; S Lin
Journal:  J Biol Chem       Date:  1980-02-10       Impact factor: 5.157

8.  Chloroquine, quinine, procaine, quinidine and clomipramine are prostaglandin agonists and antagonists.

Authors:  M S Manku; D F Horrobin
Journal:  Prostaglandins       Date:  1976-11

9.  Complement-induced histamine release from human basophils. III. Effect of pharmacologic agents.

Authors:  W A Hook; R P Siraganian
Journal:  J Immunol       Date:  1977-02       Impact factor: 5.422

10.  Chemotactic peptide receptor modulation in polymorphonuclear leukocytes.

Authors:  S J Sullivan; S H Zigmond
Journal:  J Cell Biol       Date:  1980-06       Impact factor: 10.539

View more
  3 in total

1.  Fast deactivation of guinea-pig isolated ileum to C5adesArg: a possible cyclic AMP-dependent mechanism.

Authors:  B Damerau; J Roesler; W Vogt
Journal:  Br J Pharmacol       Date:  1985-01       Impact factor: 8.739

2.  Loss and recovery of sensitivity of guinea-pig isolated ileum to the spasmogenic action of the complement peptide C5adesArg.

Authors:  B Damerau; J Roesler; W Vogt
Journal:  Br J Pharmacol       Date:  1985-01       Impact factor: 8.739

3.  Eicosanoids and histamine mediate C5a-induced electrolyte secretion in guinea pig ileal mucosa.

Authors:  J F Kachur; S Won-Kim; C Anglin; T S Gaginella
Journal:  Inflammation       Date:  1995-12       Impact factor: 4.092

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.